MyLaurel

MyLaurel raises $12M to expand home-based acute and transitional care services

3rd June, 2025

Chris Davis

Writer

MyLaurel raises $12M to expand home-based acute and transitional care services

What does MyLaurel do?

MyLaurel is a tech-enabled healthcare company that delivers on-demand home-based acute and transitional care to frail, elderly, or medically complex patients, using remote physicians and advanced technology to guide clinical care.

How much did they raise?

The company secured $12M in funding with Deerfield Management and GV as lead investors, and additional participation from Emerson Collective, Pinta Partners, and Ochsner Health, marking a significant financial boost for their operations.

What are their plans for the money?

The funds will be used to further expand the partnership with Ochsner and accelerate growth with new health system clients, potentially enhancing the accessibility and scale of its Acute Care at Home program across existing and new markets.

What have they achieved so far?

MyLaurel has already demonstrated success with its Acute Care at Home program, showing strong clinical and financial outcomes for its hospital partners through its collaboration with Ochsner.

Key Contacts

Juan Vallarino
Chief Executive Officer

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom